Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Feltner C, et al, JAMA 2021.
Notes sur les tags :
Réaliser des modifications :
Pour modifier ce document, il est nécessaire d'être connecté au site. Pour cela, assurez-vous d'avoir des identifiants valides. Si vous n'en avez pas,
contactez-nous. Pour vous connecter, cliquez sur l'icône
dans la barre de navigation.
Résumé et points clés
Importance: Hearing loss is common in older adults and associated with adverse health and social outcomes.
Objective: To update the evidence review on screening for hearing loss in adults 50 years or older to inform the US Preventive Services Task Force.
Data sources: MEDLINE, Cochrane Library, EMBASE, and trial registries through January 17, 2020; references; and experts; literature surveillance through October 8, 2020.
Study selection: English-language studies of accuracy, screening, and interventions for screen-detected or newly detected hearing loss.
Data extraction and synthesis: Dual review of abstracts, full-text articles, and study quality. Meta-analysis of screening test accuracy studies.
Main outcomes and measures: Quality of life and function, other health and social outcomes, test accuracy, and harms.
Results: Forty-one studies (N = 26 386) were included, 18 of which were new since the previous review. One trial enrolling US veterans (n = 2305) assessed the benefits of screening; there was no significant difference in the proportion of participants experiencing a minimum clinically important difference in hearing-related function at 1 year (36%-40% in the screened groups vs 36% in the nonscreened group). Thirty-four studies (n = 23 228) evaluated test accuracy. For detecting mild hearing loss (>20-25 dB), single-question screening had a pooled sensitivity of 66% (95% CI, 58%-73%) and a pooled specificity of 76% (95% CI, 68%-83%) (10 studies, n = 12 637); for detecting moderate hearing loss (>35-40 dB), pooled sensitivity was 80% (95% CI, 68%-88%) and pooled specificity was 74% (95% CI, 59%-85%) (6 studies, n = 8774). In 5 studies (n = 2820) on the Hearing Handicap Inventory for the Elderly-Screening to detect moderate hearing loss (>40 dB), pooled sensitivity was 68% (95% CI, 52%-81%) and pooled specificity was 78% (95% CI, 67%-86%). Six trials (n = 853) evaluated amplification vs control in populations with screen-detected or recently detected hearing loss over 6 weeks to 4 months. Five measured hearing-related function via the Hearing Handicap Inventory for the Elderly; only 3 that enrolled veterans (n = 684) found a significant difference considered to represent a minimal important difference (>18.7 points). Few trials reported on other eligible outcomes, and no studies reported on harms of screening or interventions.
Conclusions and relevance: Several screening tests can adequately detect hearing loss in older adults; no studies reported on the harms of screening or treatment. Evidence showing benefit from hearing aids on hearing-related function among adults with screen-detected or newly detected hearing loss is limited to studies enrolling veterans.
Références de l'article
- Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- Screening for Hearing Loss in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- Feltner C, Wallace IF, Kistler CE, Coker-Schwimmer M, Jonas DE
- JAMA
- 2021
- JAMA. 2021 Mar 23;325(12):1202-1215. doi: 10.1001/jama.2020.24855.
- Aged, Hearing Aids, Hearing Loss/*diagnosis/rehabilitation, Hearing Loss, Sensorineural/diagnosis, Hearing Tests, Humans, *Mass Screening/adverse effects/methods, Middle Aged, Practice Guidelines as Topic, Quality of Life, Risk Assessment, Sensitivity and Specificity
- Vieillissement, Longévité, Évaluation, Recommandations, Qualité_de_vie, Revue_systématique, Sensoriel, Audition
- Liens
- Traduction automatique en Français sur Google Translate
- DOI: 10.1001/jama.2020.24855
- PMID: 33755082
- Articles similaires
- Cité par
- Références
- Twitter
- Twitter cet article (lien vers l'article)
- Twitter cet article (lien vers cette page)
Éditer la discussion
Références